- Home
- URG vs PSNL Comparison
URG vs PSNL Comparison
Compare URG & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- PSNL
- Stock Information
- Founded
- URG 2004
- PSNL 2011
- Country
- URG United States
- PSNL United States
- Employees
- URG N/A
- PSNL N/A
- Industry
- URG Precious Metals
- PSNL Medical Specialities
- Sector
- URG Basic Materials
- PSNL Health Care
- Exchange
- URG Nasdaq
- PSNL Nasdaq
- Market Cap
- URG 419.5M
- PSNL 484.0M
- IPO Year
- URG N/A
- PSNL 2019
- Fundamental
- Price
- URG $1.18
- PSNL $4.60
- Analyst Decision
- URG Strong Buy
- PSNL Strong Buy
- Analyst Count
- URG 3
- PSNL 5
- Target Price
- URG $2.63
- PSNL $7.90
- AVG Volume (30 Days)
- URG 4.0M
- PSNL 1.1M
- Earning Date
- URG 08-05-2025
- PSNL 08-05-2025
- Dividend Yield
- URG N/A
- PSNL N/A
- EPS Growth
- URG N/A
- PSNL N/A
- EPS
- URG N/A
- PSNL N/A
- Revenue
- URG $39,488,000.00
- PSNL $80,317,000.00
- Revenue This Year
- URG N/A
- PSNL $0.45
- Revenue Next Year
- URG $224.22
- PSNL $25.75
- P/E Ratio
- URG N/A
- PSNL N/A
- Revenue Growth
- URG 149.20
- PSNL 0.36
- 52 Week Low
- URG $0.55
- PSNL $2.83
- 52 Week High
- URG $1.42
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- URG 45.88
- PSNL 35.07
- Support Level
- URG $1.15
- PSNL $4.57
- Resistance Level
- URG $1.29
- PSNL $4.93
- Average True Range (ATR)
- URG 0.07
- PSNL 0.33
- MACD
- URG -0.02
- PSNL -0.08
- Stochastic Oscillator
- URG 17.86
- PSNL 30.65
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.